Product Information
VERAPAMIL 120 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0858 per EA under NDC 62135074590. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
120 mg/1
Manufacturer
Chartwell RX LLCNDC
62135074590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071881On Market Since
7/20/2018
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL 120 MG TABLET has been published 133 times since Dec 13, 2023, and over the history we have for it it has risen 29.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0858 per EA |
|---|---|
| All-time high | $0.0883 (Feb 11, 2026) |
| All-time low | $0.0566 (Nov 20, 2024) |
| 52-week high | $0.0883 |
| 52-week low | $0.0731 |
| Median price | $0.0722 |
| Average price | $0.0731 |
| Largest weekly change | +20.4% (Jun 19, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 120 MG TABLET, manufactured by Chartwell RX LLC, is $0.0858 per EA (NDC 62135074590), effective Jun 24, 2026.
How has the price of VERAPAMIL 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL 120 MG TABLET has risen 29.8%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for VERAPAMIL 120 MG TABLET?
Since Dec 13, 2023, the NADAC for VERAPAMIL 120 MG TABLET has ranged from a low of $0.0566 (Nov 20, 2024) to a high of $0.0883 (Feb 11, 2026), with a median of $0.0722 per EA.
Are there cheaper alternatives to VERAPAMIL 120 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as VERAPAMIL 120 MG TABLET, but none are currently priced below it.
Who manufactures VERAPAMIL 120 MG TABLET?
VERAPAMIL 120 MG TABLET (NDC 62135074590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification